Sigachi Peer Comparison

NSE: SIGACHI | BSE: 543389

₹32.62

₹-0.54 (-1.63%)

As on 31-Aug-2026IST

Market cap

₹1,248 Cr

Revenue (TTM)

₹471 Cr

P/E Ratio

49.2

P/B Ratio

2.4

Div. Yield

0 %

Edit

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Market cap (₹ Cr)	1,248	30,606	30,088	28,551	25,816
Revenue (₹ Cr)	471	3,564	1,936	9,205	1,462
Net Profit (₹ Cr)	26.31	414.00	288.22	-371.81	387.35
Net Margin (%)	5.52	11.23	14.79	-3.93	26.01
RoE (%)	3.83	8.38	29.77	-3.85	25.18
Price to Earnings	49.24	74.83	104.39	--	66.84
Price-To-Book	2.36	6.08	22.41	3.57	14.93

Income Statement (₹ Cr)

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Operating Revenue	470.86	3,564.00	1,935.80	9,205.28	1,461.80
Total Income	476.17	3,686.00	1,948.58	9,449.59	1,489.25
Total Expenditure	424.70	2,792.00	1,485.56	8,195.15	919.25
EBITDA	46.16	772.00	450.24	1,010.13	542.56
Depreciation	17.27	226.00	50.83	857.51	37.68
EBIT	28.89	546.00	399.41	152.62	504.88
Interest	13.61	217.00	40.84	342.73	3.77
Other Income	5.31	122.00	12.78	244.31	27.45
Exceptional Items	2.79	12.00	0.00	-216.88	0.00
Profit before Tax	23.38	463.00	371.35	-162.68	528.56
Provision for Tax	-2.92	49.00	83.14	209.13	141.21
Profit after Tax	26.31	414.00	288.22	-371.81	387.35

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Shareholder's Funds	521.72	4,940.00	1,288.82	8,162.62	1,653.56
Minority Interest	-0.95	-5.00	0.00	0.00	-1.13
Non-Current Liabilities	41.82	1,712.00	202.03	5,044.14	42.40
Current Liabilities	270.47	1,622.00	835.87	4,758.28	230.82
Total Liabilities	846.21	8,100.00	1,451.43	15,513.53	1,549.26

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Non-Current Assets	326.41	5,343.00	519.60	10,211.52	1,026.85
Current Assets	389.35	2,606.00	1,681.81	7,191.66	881.27
Total Assets	846.21	8,100.00	1,451.43	15,513.53	1,549.26
Total Debt*	118.20	1,859.00	393.17	4,720.27	8.18
Net Current Assets	118.87	984.00	845.94	2,433.38	650.46
Contingent Liabilities	10.34	770.26	12.25	99.76	15.38

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Cash From Operating Activities	26.93	-22.00	159.18	892.30	118.34
Cash Flow from Investing Activities	-93.07	-783.00	-64.81	-477.46	-223.94
Cash from Financing Activities	81.10	409.00	-39.81	-440.83	261.12
Net Cash Inflow / Outflow	14.97	-396.00	54.56	-25.99	155.52

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
ROCE (%)	16.42	4.07	26.97	6.61	20.14
ROE (%)	3.83	8.38	29.77	-3.85	25.18
ROA (%)	3.12	4.94	24.77	-2.21	21.93
EBIT Margin (%)	6.13	15.32	20.63	1.66	34.54
Net Margin (%)	5.52	11.23	14.79	-3.93	26.01
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Revenue Growth (%)	-9.58	18.37	46.65	0.78	40.90
EBIT Growth (%)	-66.30	252.26	62.13	-70.53	124.50
Net Profit Growth (%)	160.80	377.85	89.49	-1,383.43	104.15
EPS Growth (%)	-76.12	1,001.33	78.60	-484.84	42.32
Book Value Growth (%)	61.70	29.77	42.49	2.28	94.96

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Price / Earnings	64.12	80.56	102.12	-93.01	69.57
Price / Book Value	2.39	6.38	22.27	3.64	15.55
Dividend Yield (%)	0.00	0.00	0.08	0.00	0.08
EV/EBITDA	28.39	43.48	66.20	32.91	49.08
Market Cap (₹ Cr)	1,342.36	23,064.69	0.00	29,731.27	19,988.69

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debt to Equity	0.00	0.31	0.11	0.53	0.01
Short term debt to equity ratio	0.20	0.11	0.54	0.12	0.02
Current Ratio	1.44	1.61	2.01	1.51	3.82
Quick Ratio	1.17	1.06	1.14	0.87	2.82
Interest Coverage	2.72	3.13	10.09	0.53	141.16

	Sigachi	Wockhardt	Rubicon Research	Piramal Pharma	Acutaas Chemicals
Debtors to sales (%)	47.61	16.50	26.28	23.44	24.80
Asset Turnover	0.56	0.43	1.66	0.55	0.83
Receivable days	124.74	60.36	47.59	77.05	90.06
Inventory Days	61.67	64.42	62.58	77.13	61.02
Payable days	68.64	218.94	228.78	173.49	96.06
Cash Conversion Cycle	117.77	-94.15	-118.62	-19.30	55.02

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.